Results	O

Table	O
1	O
shows	O
the	O
predicted	O
new	O
case	O
detection	O
rates	O
at	O
25	O
years	O
after	O
the	O
initiation	O
of	O
the	O
interventions	O
.	O

Under	O
the	O
baseline	O
control	O
program	O
,	O
the	O
different	O
mechanisms	O
that	O
determined	O
susceptibility	O
showed	O
up	O
to	O
three	O
-	O
fold	O
differences	O
in	O
the	O
predicted	O
number	O
of	O
cases	O
per	O
100	O
,	O
000	O
people	O
.	O

In	O
Figure	O
1	O
,	O
the	O
trends	O
in	O
the	O
new	O
case	O
detection	O
rates	O
over	O
50	O
years	O
are	O
shown	O
for	O
all	O
seven	O
interventions	O
.	O

All	O
susceptibility	O
mechanisms	O
give	O
qualitatively	O
comparable	O
trends	O
.	O

When	O
the	O
intervention	O
scenarios	O
were	O
ordered	O
after	O
50	O
years	O
by	O
the	O
amount	O
of	O
reduction	O
in	O
new	O
case	O
detection	O
rates	O
,	O
the	O
order	O
was	O
as	O
good	O
as	O
identical	O
for	O
all	O
mechanisms	O
;	O
i	O
.	O
e	O
.	O
early	O
diagnosis	O
lowest	O
;	O
then	O
no	O
BCG	O
&	O
early	O
diagnosis	O
;	O
then	O
chemoprophylaxis	O
;	O
then	O
baseline	O
;	O
then	O
no	O
BCG	O
&	O
chemoprophylaxis	O
together	O
with	O
no	O
contact	O
tracing	O
;	O
and	O
finally	O
no	O
BCG	O
had	O
the	O
highest	O
new	O
case	O
detection	O
rate	O
.	O

10	O
.	O
1371	O
/	O
journal	O
.	O
pntd	O
.	O
0001330	O
.	O
g001	O
Figure	O
1	O

Predicted	O
decline	O
of	O
the	O
new	O
case	O
detection	O
rate	O
with	O
seven	O
intervention	O
scenarios	O
and	O
six	O
mechanisms	O
of	O
leprosy	O
susceptiblity	O
since	O
start	O
of	O
intervention	O
strategy	O
.	O

The	O
baseline	O
program	O
(	O
black	O
line	O
)	O
included	O
passive	O
detection	O
,	O
multidrug	O
therapy	O
,	O
contact	O
tracing	O
,	O
and	O
an	O
infant	O
leprosy	O
-	O
preventative	O
BCG	O
vaccination	O
given	O
at	O
the	O
population	O
level	O
.	O

The	O
other	O
six	O
intervention	O
strategies	O
included	O
the	O
baseline	O
program	O
and	O
,	O
introduction	O
of	O
a	O
new	O
tuberculosis	O
vaccine	O
ineffective	O
against	O
leprosy	O
replacing	O
BCG	O
(	O
red	O
)	O
;	O
no	O
tracing	O
of	O
household	O
contacts	O
(	O
orange	O
)	O
;	O
a	O
single	O
chemoprophylactic	O
dose	O
of	O
rifampicin	O
that	O
cured	O
50	O
%	O
of	O
subclinically	O
infected	O
contacts	O
(	O
yellow	O
)	O
;	O
early	O
diagnosis	O
of	O
70	O
%	O
of	O
subclinically	O
infected	O
contacts	O
in	O
each	O
of	O
3	O
consecutive	O
annual	O
examinations	O
(	O
green	O
)	O
;	O
chemoprophylaxis	O
plus	O
introduction	O
of	O
a	O
tuberculosis	O
vaccine	O
ineffective	O
against	O
leprosy	O
(	O
blue	O
)	O
;	O
and	O
detection	O
of	O
subclinically	O
infected	O
contacts	O
plus	O
introduction	O
of	O
a	O
tuberculosis	O
vaccine	O
ineffective	O
against	O
le	O
-	O
pro	O
-	O
sy	O
(	O
purple	O
)	O
.	O

Results	O
are	O
the	O
average	O
of	O
100	O
runs	O
of	O
the	O
simulation	O
model	O
for	O
each	O
scenario	O
and	O
susceptibilty	O
mechanism	O
.	O

10	O
.	O
1371	O
/	O
journal	O
.	O
pntd	O
.	O
0001330	O
.	O
t001	O
Table	O
1	O

Predicted	O
new	O
case	O
detection	O
rates	O
(	O
per	O
100	O
,	O
000	O
)	O
at	O
25	O
years	O
after	O
the	O
introduction	O
of	O
the	O
indicated	O
intervention	O
scenario	O
for	O
six	O
mechanisms	O
of	O
leprosy	O
susceptibility	O
as	O
described	O
in	O
[	O
9	O
]	O
.	O

Intervention	O
Mechanism	O
determining	O
susceptibilty	O

Random	O
Household	O
Dominant	O
Recessive	O
Household	O
&	O
dominant	O
Household	O
&	O
recessive	O

Baseline	O
control	O
3	O
.	O
4	O
4	O
.	O
0	O
10	O
.	O
4	O
8	O
.	O
2	O
5	O
.	O
6	O
4	O
.	O
6	O

No	O
BCG	O
4	O
.	O
6	O
5	O
.	O
5	O
15	O
.	O
0	O
11	O
.	O
9	O
7	O
.	O
6	O
6	O
.	O
4	O

No	O
contact	O
tracing	O
3	O
.	O
8	O
4	O
.	O
1	O
10	O
.	O
5	O
8	O
.	O
5	O
5	O
.	O
5	O
4	O
.	O
8	O

Chemoprophylaxis	O
2	O
.	O
8	O
3	O
.	O
2	O
6	O
.	O
9	O
5	O
.	O
9	O
4	O
.	O
1	O
3	O
.	O
4	O

Early	O
diagnosis	O
1	O
.	O
1	O
2	O
.	O
1	O
2	O
.	O
7	O
2	O
.	O
6	O
2	O
.	O
1	O
2	O
.	O
0	O

No	O
BCG	O
&	O
chemoprophylaxis	O
3	O
.	O
6	O
4	O
.	O
0	O
10	O
.	O
5	O
8	O
.	O
5	O
5	O
.	O
9	O
5	O
.	O
1	O

No	O
BCG	O
&	O
early	O
diagnosis	O
1	O
.	O
2	O
2	O
.	O
5	O
3	O
.	O
7	O
3	O
.	O
7	O
2	O
.	O
9	O
2	O
.	O
8	O

The	O
results	O
are	O
average	O
of	O
100	O
runs	O
of	O
the	O
simulation	O
model	O
.	O

Both	O
the	O
cessation	O
of	O
contact	O
tracing	O
and	O
the	O
replacement	O
of	O
BCG	O
vaccine	O
by	O
a	O
tuberculosis	O
vaccine	O
ineffective	O
for	O
leprosy	O
(	O
no	O
BCG	O
)	O
would	O
have	O
detrimental	O
effects	O
on	O
the	O
rate	O
of	O
decline	O
in	O
leprosy	O
(	O
Figure	O
2	O
)	O
.	O

Twenty	O
-	O
five	O
years	O
after	O
introduction	O
of	O
the	O
ineffective	O
vaccine	O
(	O
no	O
BCG	O
)	O
,	O
the	O
new	O
case	O
detection	O
of	O
leprosy	O
was	O
approximately	O
1	O
.	O
5	O
times	O
higher	O
than	O
the	O
baseline	O
(	O
Table	O
1	O
)	O
.	O

The	O
cessation	O
of	O
contact	O
tracing	O
was	O
predicted	O
to	O
have	O
a	O
smaller	O
impact	O
,	O
with	O
a	O
marked	O
drop	O
in	O
detection	O
of	O
new	O
leprosy	O
cases	O
during	O
the	O
first	O
few	O
years	O
.	O

This	O
sudden	O
drop	O
was	O
due	O
to	O
the	O
reduced	O
number	O
of	O
examinations	O
of	O
people	O
in	O
contact	O
with	O
patients	O
;	O
thus	O
,	O
these	O
cases	O
would	O
not	O
be	O
detected	O
until	O
later	O
,	O
through	O
passive	O
detection	O
(	O
self	O
-	O
reporting	O
)	O
.	O

10	O
.	O
1371	O
/	O
journal	O
.	O
pntd	O
.	O
0001330	O
.	O
g002	O
Figure	O
2	O

Predicted	O
new	O
case	O
detection	O
rates	O
for	O
six	O
intervention	O
scenarios	O
relative	O
to	O
the	O
baseline	O
control	O
program	O
.	O

For	O
each	O
intervention	O
scenario	O
simulations	O
with	O
different	O
mechanisms	O
of	O
susceptibility	O
to	O
leprosy	O
,	O
as	O
defined	O
in	O
our	O
previous	O
paper	O
[	O
9	O
]	O
are	O
performed	O
.	O

For	O
each	O
intervention	O
scenario	O
,	O
the	O
two	O
dotted	O
lines	O
show	O
the	O
smallest	O
and	O
largest	O
deviations	O
from	O
the	O
baseline	O
control	O
program	O
.	O

The	O
solid	O
line	O
shows	O
the	O
median	O
of	O
all	O
susceptibility	O
mechanisms	O
.	O

Results	O
are	O
the	O
average	O
of	O
100	O
runs	O
of	O
the	O
simulation	O
model	O
.	O

Both	O
chemoprophylaxis	O
and	O
early	O
diagnosis	O
were	O
predicted	O
to	O
have	O
substantial	O
effects	O
on	O
the	O
new	O
case	O
detection	O
of	O
leprosy	O
(	O
Figure	O
2	O
)	O
.	O

With	O
no	O
BCG	O
,	O
chemoprophylaxis	O
would	O
partially	O
compensate	O
for	O
the	O
predicted	O
increase	O
in	O
new	O
case	O
detection	O
rates	O
.	O

Furthermore	O
,	O
early	O
diagnosis	O
was	O
predicted	O
to	O
more	O
than	O
compensate	O
for	O
the	O
adverse	O
effects	O
of	O
a	O
leprosy	O
-	O
ineffective	O
tuberculosis	O
vaccine	O
,	O
and	O
reduce	O
the	O
rate	O
of	O
new	O
case	O
detection	O
compared	O
to	O
the	O
baseline	O
.	O

The	O
effects	O
were	O
more	O
promising	O
with	O
the	O
ongoing	O
presence	O
of	O
the	O
BCG	O
vaccine	O
.	O

Under	O
those	O
conditions	O
,	O
at	O
25	O
years	O
after	O
the	O
introduction	O
of	O
chemoprophylaxis	O
,	O
the	O
new	O
case	O
detection	O
rate	O
was	O
predicted	O
to	O
be	O
25	O
%	O
lower	O
than	O
baseline	O
control	O
.	O

Moreover	O
,	O
with	O
the	O
introduction	O
of	O
early	O
diagnosis	O
,	O
the	O
new	O
case	O
detection	O
rate	O
was	O
predicted	O
to	O
halve	O
the	O
baseline	O
incidence	O
after	O
25	O
years	O
(	O
Table	O
1	O
)	O
.	O

Early	O
diagnosis	O
of	O
infection	O
allows	O
the	O
detection	O
of	O
subclinical	O
cases	O
,	O
of	O
which	O
part	O
would	O
be	O
detected	O
later	O
or	O
never	O
at	O
all	O
.	O

These	O
subclinical	O
cases	O
are	O
added	O
to	O
the	O
number	O
of	O
detected	O
cases	O
.	O

This	O
is	O
seen	O
in	O
the	O
results	O
of	O
this	O
intervention	O
.	O

The	O
introduction	O
of	O
early	O
diagnosis	O
would	O
increase	O
the	O
total	O
number	O
of	O
detected	O
cases	O
in	O
the	O
first	O
18	O
years	O
,	O
simply	O
because	O
of	O
the	O
detection	O
of	O
previously	O
undetectable	O
subclinical	O
cases	O
.	O

Over	O
time	O
however	O
,	O
the	O
total	O
number	O
of	O
new	O
cases	O
(	O
subclinical	O
and	O
clinical	O
)	O
would	O
finally	O
drop	O
below	O
the	O
number	O
detected	O
in	O
the	O
baseline	O
control	O
program	O
(	O
Figure	O
3	O
)	O
.	O

In	O
Figure	O
3	O
,	O
we	O
show	O
that	O
the	O
new	O
cases	O
detected	O
under	O
the	O
chemoprophylaxis	O
intervention	O
strategy	O
drop	O
immediately	O
below	O
the	O
level	O
of	O
the	O
baseline	O
control	O
program	O
.	O

The	O
additional	O
effect	O
of	O
chemoprophylaxis	O
is	O
that	O
additional	O
new	O
infections	O
are	O
prevented	O
on	O
top	O
of	O
the	O
cure	O
of	O
subclinical	O
infections	O
.	O

These	O
additional	O
prevented	O
infections	O
are	O
due	O
to	O
a	O
shorter	O
infectious	O
period	O
of	O
the	O
cured	O
subclinical	O
infections	O
.	O

To	O
illustrate	O
this	O
effect	O
we	O
show	O
in	O
Figure	O
3	O
the	O
clinical	O
and	O
the	O
subclinical	O
cases	O
that	O
were	O
cured	O
by	O
the	O
chemoprophylactic	O
intervention	O
.	O

During	O
the	O
first	O
10	O
years	O
,	O
this	O
total	O
number	O
of	O
newly	O
detected	O
cases	O
plus	O
cured	O
cases	O
is	O
equal	O
to	O
the	O
number	O
of	O
newly	O
detected	O
cases	O
under	O
the	O
baseline	O
control	O
program	O
,	O
but	O
afterwards	O
the	O
number	O
of	O
cases	O
plus	O
cured	O
subclinical	O
cases	O
in	O
the	O
chemoprophylaxis	O
intervention	O
group	O
drops	O
under	O
the	O
baseline	O
control	O
program	O
,	O
indicating	O
the	O
prevention	O
of	O
new	O
infections	O
.	O

10	O
.	O
1371	O
/	O
journal	O
.	O
pntd	O
.	O
0001330	O
.	O
g003	O
Figure	O
3	O

Cumulative	O
New	O
cases	O
detected	O
of	O
leprosy	O
per	O
person	O
-	O
year	O
since	O
start	O
of	O
the	O
interventions	O
.	O

Results	O
are	O
the	O
average	O
of	O
100	O
runs	O
of	O
the	O
simulation	O
model	O
.	O

